Role of Quantitative HBsAg Testing in Clinical Practice for People With CHB
Listen as Ira M. Jacobson, MD; Paul Y. Kwo, MD; and Tatyana Kushner, MD, MSCE, discuss the role of quantitative HBsAg testing in current clinical practice and where it may play a role in the future.
Decera Clinical Education Infectious Disease Podcast · Paul Y. Kwo MD, Ira M. Jacobson MD, Tatyana Kushner MD MSCE
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Should quantitative HBsAg testing be used routinely in clinical practice for patients living with chronic hepatitis B?
In this episode, Tatyana Kushner, MD, MSCE, discusses the role of quantitative hepatitis B surface antigen testing in people living with chronic hepatitis B, including:
- Determination of inactive carrier status
- Prediction of liver fibrosis/cirrhosis
- Prediction of hepatocellular carcinoma development
- Monitoring response to treatment, including future HBV treatments in the development pipeline
- Prediction of HBsAg loss
Joining her for the panel discussion are Ira M. Jacobson, MD, and Paul Y. Kwo, MD.
Presenters:
Ira M. Jacobson, MD
Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York
Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at
Mount Sinai
New York, New York
Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California
Link to the full program:
https://bit.ly/3R1PMi4
Link to the slides:
https://bit.ly/3N5Fpsm
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.